Table 2.
Proteins differentially expressed in the serum of control and HT-treated stroke patients.
| HT Treatment | |||||
|---|---|---|---|---|---|
| 45 vs. 0 | |||||
| Uniprot ID | Protein Name | Abbreviation | Gene | Fold Change | p Value |
| 000533 | Neural cell adhesion molecule L1-like protein | NC HL1 | CHL1 | 1.912 | 0.026 |
| Q9UGM5 | Fetuin-B | FETUB | FETUB | 1.359 | 0.045 |
| P07339 | Cathepsin D | CATD | CTSD | −1.169 | 0.012 |
| P04114 | Apolipoprotein B-100 | APOB | APOB | −1.655 | 0.014 |
| Q9UHG3 | Prenylcysteine oxidase | PCYOX | PCYOX1 | −1.716 | 0.030 |
| P02649 | Apolipoprotein E | APOE | APOE | −1.891 | 0.000 |
| O95445 | Apolipoprotein M | APOM | APOM | −1.968 | 0.039 |
| Q13740 | CD166 antigen | CD166 | ALCAM | −2.192 | 0.039 |
| Q005469 | Hormone- sensitive lipase | LIPS | LIPE | −3.229 | 0.041 |
| 90 vs. 45 | |||||
| Uniprot ID | PrSSotein name | Abbreviation | Gene | Fold change | p value |
| P02766v109B | Transthyretinv109B | TTR | TTR | 6.972 | 0.048 |
| Q8N1N4 | Keratin type I cytoskeletal 78 | K2C78 | KRT78 | 5.137 | 0.043 |
| 90 vs. 0 | |||||
| Uniprot ID | Protein name | Abbreviation | Gene | Fold change | p value |
| P55065 | Apolipoprotein A-IV | APC )A4 | APOA4 | 2.987 | 0.008 |
| P06727 | Glutaminyl-peptide cydotransferase | QPCT | QPCT | 2.189 | 0.023 |
| Q16769 | Keratin type I cytoskeletal 14 | K1C14 | KRT14 | 1.704 | 0.031 |
| P00558 | Fetuin-B | FETUB | FETUB | 1.554 | 0.038 |
| P02533 | Hyaluronan-binding protein 2 | HABP2 | HABP2 | 1.44 | 0.037 |
| Q14520 | Phosphoglycerate kinase | PGK1 | PGK1 | −1.268 | 0.030 |
| Q9UGM5 | Apolipoprotein M | APC DM | APC DM | −1.927 | 0.043 |
| P02654 | Apolipoprotein C-I | APOC 1 | APOC 1 | −2.624 | 0.042 |
| O95445 | Apolipoprotein C-IV | APOC 4 | APOC4 | −6.702 | 0.006 |
| CONTROL | |||||
| 45 vs. 0 | |||||
| Uniprot ID | Protein name | Abbreviation | Gene | Fold change | p value |
| P06727 | Apolipoprotein A-IV | APOA4 | APOA4 | 2.903 | 0.032 |
| O43505 | Beta-1 4-glucuronyltransferase 1 | B4GA1 | B4GAT1 | 2.274 | 0.002 |
| Q12860 | Contactin-1 | CNTN1 | CNTN1 | 2.107 | 0.037 |
| P01008 | Antithrombin-III | ANT3 | SERPINC1 | 1.495 | 0.040 |
| P06681 | Complement C2 | CO2 | C2 | 1.138 | 0.034 |
| P04180 | Phosphatidylcholine -sterol acyltransferase | LCAT | LCAT | −1.389 | 0.023 |
| P22352 | Glutathione peroxidase 3 | GPX3 | GPX3 | −1.572 | 0.042 |
| P04066 | Tissue alpha-L-fucosidase | FUCO | FUC A1 | −3.751 | 0.007 |
| 90 vs. 45 | |||||
| Uniprot ID | Protein name | Abbreviation | Gene | Fold change | p value |
| Q6YHK3 | CD109 antigen | CD109 | CD109 | 3.72 | 0.034 |
| O14818 | Proteasome subunit alpha type-7 | PSA7 | PSMA7 | 1.494 | 0.028 |
| P35542 | Serum amyloid A-4 protein | SAA4 | SAA4 | −1.404 | 0.030 |
| Q5TZA2 | Rootletin | CROCC | CROCC | −1.454 | 0.042 |
| O43505 | Beta-1 4-glucuronyltransferase 1 | B4GA1 | B4GAT1 | −2.695 | 0.029 |
| P00740 | Coagulation factor IX | FA9 | F9 | −3.156 | 0.024 |
| P16157 | Ankyrin-1 | ANK1 | ANK1 | −9.475 | 0.022 |
| 90 vs. 0 | |||||
| Uniprot ID | Protein name | Abbreviation | Gene | Fold change | p value |
| Q6YHK3 | CD109 antigen | CD109 | CD109 | 8.496 | 0.016 |
| A0A075B6H7 | Probable non-functional immunoglobulin kappa variable 3-7 | KV37 | IGKV3 | 7.943 | 0.044 |
| Q12860 | Contactin-1 | CNTN1 | CNTN1 | 6.574 | 0.020 |
| P06727 | Apolipoprotein A-IV | APOA4 | APC )A4 | 3.089 | 0.013 |
| P00352 | Retinal dehydrogenase 1 | AL1A1 | ALDH1A1 | 1.911 | 0.042 |
| P01008 | Antithrombin-III | ANT3 | SERPINC1 | 1.46 | 0.014 |
| P35542 | Serum amyloid A-4 | SAA4 | SAA4 | −1.805 | 0.025 |
| P02652 | Apolipoprotein A-II | APOA2 | APOA2 | −1.991 | 0.050 |
| P01591 | Immunoglobulin J chain | IGJ | JCHAIN | −2.23 | 0.025 |
| P02654 | Apolipoprotein C-I | APOC1 | APOC1 | −3.188 | 0.037 |
| P00740 | Coagulation factor IX | FA9 | F9 | −3.298 | 0.035 |
| A0A0C4DH67 | Immunoglobulin kappa variable 1-8 | KV108 | IGKV1 | −3.952 | 0.018 |
| O95445 | Apolipoprotein M | APOM | APOM | −3.984 | 0.030 |
| P04066 | Tissue alpha-L-fucosidase | FUCO | FUCA1 | −8.264 | 0.035 |
| Q03591 | Complement factor H-related protein 1 | FHR1 | CFHR1 | −26.803 | 0.050 |